Tau Ventures

Tau Ventures is an AI-first, early-stage venture capital firm specializing in investments within healthcare, enterprise software, and automation sectors. The firm primarily targets seed-stage opportunities but selectively participates in Series A, B, and later rounds, with initial check sizes typically ranging from $100K to $500K. Leveraging deep sector expertise and an operator mindset, Tau Ventures supports portfolio companies in accelerating go-to-market strategies and scaling mission-critical technologies, backed by a robust network and quarterly community events.

Founded in 2019 and headquartered in Palo Alto, California, Tau Ventures was co-founded by Amit Garg, who brings extensive experience from roles at Samsung NEXT Ventures, Norwest Venture Partners, Google, and as co-founder of HealthIQ. The firm manages multiple funds including Fund I, Fund II, and Opty Fund, with assets under management reported between $20M+ and $86M across sources. Operating from Silicon Valley with additional presence in DC, NYC, LA, and SF, Tau Ventures emphasizes AI-driven innovations to transform early-stage ideas into scalable businesses.

The firm's portfolio includes over 30 companies and 108 investments, featuring notable names such as Assort Health, Infinitus Systems, Vecna Robotics, ArmorCode, AmplifyMD, Cerby, Autonomize, and Oath Surgical. Recent activity shows strong deal flow with 10 deals in the last 6 months and 21 in the last 12 months, spanning digital health, enterprise AI, fintech, and automation, though no exits are reported to date.

Tau Ventures boasts a high-caliber team with elite academic and professional pedigrees. Partners include Amit Garg (Stanford BS/MS, Harvard MBA) focusing on digital health and automation, and Sanjay Rao (MIT degrees, Harvard MBA) on enterprise and automation. Principals such as Sharon Huang (Stanford CS/epidemiology), Insoo Chang (Cornell/Harvard, fintech focus), and Sam Bogrov (Wharton MBA, healthcare) bring complementary expertise in engineering, strategy, medicine, and operations from prior roles at Novartis, Citigroup, McKinsey, Microsoft, and private equity firms.